News
The La mañana de la 1 program, broadcast by Televisión Española (TVE), devoted its saber vivir health section to the treatment of osteoarthritis.
The 19th edition of the symposium on glyccosaminoglyccans New developments of anticoagulant and non-anticoagulant glycosaminoglycans and of other coagulation inhibitors, is the most important meeting dealing with glycosaminoglycans. It will be held on 22-24 September 2011 at Villa Vigoni (Loveno, Lake Como)
Bioiberica has recently formed a German subsidiary, BIOIBERICA GmbH, headed up by Mr Axel Schmidt.
Bioiberica closed 2009 with a turnover of $152 million and significant growth compared to the previous year. These results indicate that the company is on the right track and heading for a promising future.
Bioiberica has followed a vertical integration strategy in the last three years towards the development and sale of finished products. All products undergo scientific and clinical development and have their own marketing strategy to support sales in each country.